NFKB1 and brain inflammatory disease: MiR-146a was involved in the regulation of brain inflammation by modulating TRAF6/NF-κB or MAPK signaling pathways and could be considered a novel therapeutic agent for treating brain inflammation (Liu et al., 2020).